Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Treatment of vascular calcification

A technology of vascular calcification and solvate, which is used in the field of compounds for the treatment of medial vascular calcification or intimal atherosclerotic calcification, and can solve problems such as adverse effects on mechanical properties of vascular tissue and matrix hardening.

Active Publication Date: 2019-03-15
CAMBRIDGE ENTERPRISE LTD +1
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Calcification leads to hardening of the matrix, which is essential for bone but has an adverse effect on the mechanical properties of vascular tissue

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Treatment of vascular calcification
  • Treatment of vascular calcification
  • Treatment of vascular calcification

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0133] Example 1: Demonstration of the physiological link between poly(ADP ribose) (PAR) and vascular calcification;

Embodiment 2

[0134] Embodiment 2: detecting the toxicity of PARP inhibitor / tetracycline to bovine vascular smooth muscle cells;

Embodiment 3

[0135] Embodiment 3: Detect the toxicity of PARP inhibitor / tetracycline to human monocyte macrophage;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the use of a poly(ADP ribose) polymerase (PARP) inhibitor and / or a tetracycline, for treating, preventing or ameliorating medial vascular calcification or intimal atherosclerotic calcification, and to pharmaceutical compositions comprising PARP inhibitors or tetracycline.

Description

technical field [0001] The present invention relates to vascular calcification, and in particular to compounds useful in the treatment of diseases associated with excessive and / or inappropriate vascular calcification. In particular, the invention relates to the treatment of medial vascular calcification or intimal atherosclerotic calcification. The present invention relates to pharmaceutical compositions and methods for the treatment of excessive and / or inappropriate (ie, medial) vascular calcification. Background technique [0002] Vascular calcification is associated with a range of diseases and can be broadly classified into three distinct types, namely (1) intimal atherosclerotic calcification, which is intimal calcification and includes atherosclerosis and associated inflammation; (2) valvular calcification aortic stenosis, which is calcification of the aortic valve; and (3) medial calcification, which is calcification of the media, see Demer and Tintut "Vascular Calci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4184A61K31/454A61K31/4709A61K31/502A61K31/5025A61K31/55A61K31/65A61K45/06A61P9/10A61P9/14
CPCA61K45/06A61K31/4184A61K31/454A61K31/502A61K31/5025A61K31/55A61K31/47A61K31/50A61K31/166A61K31/4709A61K31/473A61K31/506A61K31/519A61K31/522A61K31/554A61K31/65A61P43/00A61P9/00A61P9/10A61P9/14A61K2300/00
Inventor M·杜尔D·里德C·沙纳汉
Owner CAMBRIDGE ENTERPRISE LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com